Spatial heterogeneity of
KRAS mutation
carcinogens
colorectal cancer
highways
spatial scan statistics
Journal
Cancer management and research
ISSN: 1179-1322
Titre abrégé: Cancer Manag Res
Pays: New Zealand
ID NLM: 101512700
Informations de publication
Date de publication:
2019
2019
Historique:
received:
04
04
2019
accepted:
25
07
2019
entrez:
2
10
2019
pubmed:
2
10
2019
medline:
2
10
2019
Statut:
epublish
Résumé
Somatic mutations in the In this study, we attempted to identify the potential geographical population clusters of All patients with CRC who were identified to have A mutation at There was a spatial heterogeneity and a greater frequency of
Sections du résumé
BACKGROUND
BACKGROUND
Somatic mutations in the
PURPOSE
OBJECTIVE
In this study, we attempted to identify the potential geographical population clusters of
PATIENTS AND METHODS
METHODS
All patients with CRC who were identified to have
RESULTS
RESULTS
A mutation at
CONCLUSION
CONCLUSIONS
There was a spatial heterogeneity and a greater frequency of
Identifiants
pubmed: 31571990
doi: 10.2147/CMAR.S211119
pii: 211119
pmc: PMC6750880
doi:
Types de publication
Journal Article
Langues
eng
Pagination
8337-8344Informations de copyright
© 2019 Turpin et al.
Déclaration de conflit d'intérêts
A travel grant by Sanofi-Genzyme was obtained by Anthony Turpin. Dr Anthony Turpin reports personal fees from Amgen, Merck, Servier, and grants from Astra-Zeneca, Pfizer, outside of the submitted work. Dr Clotilde Descarpentries reports non-financial support from Astra-Zeneca and Roche, outside the submitted work. The authors report no other conflicts of interest in this work.
Références
J Clin Oncol. 2008 Sep 1;26(25):4217-9
pubmed: 18757341
J Exp Clin Cancer Res. 2018 Mar 13;37(1):57
pubmed: 29534749
Clin Transl Gastroenterol. 2017 Oct 19;8(10):e124
pubmed: 29048416
Age Ageing. 2017 Jul 1;46(4):607-613
pubmed: 28064169
BMC Gastroenterol. 2014 Apr 10;14:73
pubmed: 24720724
Oncol Lett. 2015 Oct;10(4):2519-2526
pubmed: 26622882
Clin Transl Oncol. 2011 Sep;13(9):664-71
pubmed: 21865138
J Clin Oncol. 2008 Apr 1;26(10):1626-34
pubmed: 18316791
Int J Cancer. 2009 Jul 1;125(1):158-64
pubmed: 19358278
Target Oncol. 2011 Sep;6(3):133-45
pubmed: 21630045
Med Oncol. 2013;30(3):617
pubmed: 23729268
Eur J Emerg Med. 2019 Jun;26(3):180-187
pubmed: 29303842
Oncologist. 2008 Dec;13(12):1270-5
pubmed: 19056857
Environ Health Perspect. 2017 Aug 21;125(8):087013
pubmed: 28886601
J Epidemiol Community Health. 2012 Nov;66(11):982-9
pubmed: 22544918
Cancer Metastasis Rev. 2018 Mar;37(1):173-187
pubmed: 29322354
BMC Public Health. 2012 Aug 01;12:589
pubmed: 22852770
Cancer Med. 2013 Feb;2(1):11-20
pubmed: 24133623
Spat Spatiotemporal Epidemiol. 2013 Mar;4:33-49
pubmed: 23481252
Stat Med. 2006 Nov 30;25(22):3929-43
pubmed: 16435334
Stat Med. 1995 Nov 15-30;14(21-22):2411-31
pubmed: 8711278
N Engl J Med. 1988 Sep 1;319(9):525-32
pubmed: 2841597
PLoS One. 2014 Jun 11;9(2):e98964
pubmed: 24918610
Chemosphere. 2018 Oct;209:623-631
pubmed: 29957523
Int J Cancer. 2017 Apr 1;140(7):1485-1493
pubmed: 27943267
Ann Oncol. 2016 Aug;27(8):1386-422
pubmed: 27380959
Environ Health. 2016 Jan 14;15:4
pubmed: 26762540
J Clin Oncol. 2008 Jan 20;26(3):374-9
pubmed: 18202412
N Engl J Med. 2013 Sep 12;369(11):1023-34
pubmed: 24024839